• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐药肿瘤的治疗方法。

Therapeutic approach to drug resistant tumors.

作者信息

Naito M, Tsuruo T

机构信息

Institute of Molecular and Cellular Biosciences, The University of Tokyo, Japan.

出版信息

Ther Drug Monit. 1998 Oct;20(5):577-80. doi: 10.1097/00007691-199810000-00022.

DOI:10.1097/00007691-199810000-00022
PMID:9780138
Abstract

Drug resistance is a major problem in cancer chemotherapy. P-glycoprotein plays a major role in multidrug resistance in cancer cells. P-glycoprotein is expressed in some normal tissues and has physiological functions. These include protecting the brain against toxic substances at the blood-brain barrier site, excreting toxic substances from the liver, kidney, and gastrointestinal tracts, and transporting steroidal hormones in the adrenal grand. Once expressed in cancer cells. P-glycoprotein effluxes a variety of anticancer drugs, such as doxorubicin, vinca alkaloids, etoposide and taxol, and thereby allows cancer cells to show resistance to these drugs.

摘要

耐药性是癌症化疗中的一个主要问题。P-糖蛋白在癌细胞的多药耐药中起主要作用。P-糖蛋白在一些正常组织中表达并具有生理功能。这些功能包括在血脑屏障部位保护大脑免受有毒物质侵害、从肝脏、肾脏和胃肠道排泄有毒物质,以及在肾上腺中运输甾体激素。一旦在癌细胞中表达,P-糖蛋白就会排出多种抗癌药物,如阿霉素、长春花生物碱、依托泊苷和紫杉醇,从而使癌细胞对这些药物产生耐药性。

相似文献

1
Therapeutic approach to drug resistant tumors.耐药肿瘤的治疗方法。
Ther Drug Monit. 1998 Oct;20(5):577-80. doi: 10.1097/00007691-199810000-00022.
2
Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.人前列腺癌细胞系DU 145、PC-3、PPC-1和TSU-PR1的阿霉素耐药变体:抗肿瘤药物敏感性生化决定因素的特征分析
Int J Oncol. 2000 Dec;17(6):1077-86. doi: 10.3892/ijo.17.6.1077.
3
Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.乳腺癌耐药蛋白/多药耐药相关蛋白、多药耐药相关蛋白1和多药耐药蛋白1/ P-糖蛋白对非典型和经典多药耐药癌细胞耐热变体的影响。
Int J Cancer. 2002 Feb 20;97(6):751-60. doi: 10.1002/ijc.10131.
4
Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.人膀胱癌细胞系中由非P-糖蛋白介导的非典型多药耐药性
Jpn J Cancer Res. 1995 Nov;86(11):1112-8. doi: 10.1111/j.1349-7006.1995.tb03028.x.
5
Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.P-糖蛋白抑制剂对多药耐药性的调节与预防
Cancer Chemother Pharmacol. 1997;40 Suppl:S13-9. doi: 10.1007/s002800051055.
6
Lung resistance-related protein: determining its role in multidrug resistance.
J Natl Cancer Inst. 1999 Oct 6;91(19):1604-5. doi: 10.1093/jnci/91.19.1604.
7
Kinetics of the P-glycoprotein, the multidrug transporter.多药转运蛋白P-糖蛋白的动力学
Exp Physiol. 1998 Mar;83(2):221-32. doi: 10.1113/expphysiol.1998.sp004106.
8
Multidrug resistance in brain tumors: roles of the blood-brain barrier.脑肿瘤中的多药耐药性:血脑屏障的作用
Cancer Metastasis Rev. 2001;20(1-2):13-25. doi: 10.1023/a:1013104423154.
9
Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.小鼠骨肉瘤细胞对化疗药物的内在抗性
J Bone Joint Surg Am. 2000 Jul;82-A(7):963-9. doi: 10.2106/00004623-200007000-00008.
10
Resistance to anticancer drugs: are we ready to use biologic information for the treatment of patients with cancer?
Ther Drug Monit. 1998 Oct;20(5):581-7. doi: 10.1097/00007691-199810000-00023.

引用本文的文献

1
Membrane Transporters and Pharmacological Implications.膜转运蛋白及其药理学意义。
J Pharmacovigil. 2016 Jun;4(3). doi: 10.4172/2329-6887.1000e155. Epub 2016 Jun 8.
2
Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors.新型紫杉烷类化合物的抗肿瘤活性,其同时作为细胞毒性剂和P-糖蛋白抑制剂发挥作用。
Br J Cancer. 2000 Dec;83(12):1762-8. doi: 10.1054/bjoc.2000.1500.